Bayer | BAYN - Capital De Empréstimo

Preço das Ações
38.52
Mudança Diária
0.69 1.82%
Mensal
-6.87%
Anual
64.40%
Q2 Previsão
36.73




Capital De Empréstimo Alterar Data
Air Liquide EUR 11.06B 1.39B 2025-12
Akzo Nobel EUR 4.76B 1.09B 2026-03
Alcon AG USD 4.16B 434M 2026-03
Arkema EUR 3.81B 6.6M 2026-03
AstraZeneca USD 25.96B 177M 2026-03
BASF EUR 18.48B 447M 2025-12
Bayer EUR 30.68B 1.15B 2026-03
Beiersdorf EUR 117M 15M 2025-12
Corteva USD 1.68B 4M 2026-03
Covestro EUR 1.67B 408M 2025-12
Essilor EUR 9.46B 92M 2025-12
Fresenius EUR 9.22B 1.58B 2025-12
Fresenius Medical Care EUR 5.74B 895.27M 2026-03
Genmab DKK 5.14B 5.01B 2025-12
Givaudan CHF 4.19B 448M 2025-12
GlaxoSmithKline GBP 14.01B 696M 2026-03
GRIFOLS EUR 9.08B 612M 2026-03
Henkel EUR 1.38B 627M 2025-12
Hikma Pharmaceutical USD 1.49B 692M 2025-12
Johnson Matthey GBP 1.34B 3M 2025-12
Linde USD 20.68B 2.09B 2025-12
Lonza CHF 3.88B 323M 2025-12
Merck EUR 10.8B 72M 2026-03
Novartis USD 37.45B 7.86B 2026-03
Nutrien USD 9.78B 505M 2026-03
Philips EUR 6.89B 43M 2026-03
PPG Industries USD 6.41B 195M 2026-03
Roche Holding CHF 27.43B 966M 2025-12
Sanofi EUR 13.84B 1.88B 2026-03
SAP EUR 5.04B 983M 2026-03
Solvay EUR 1.83B 8M 2026-03
UCB EUR 2.18B 634M 2025-12
Umicore EUR 2.24B 10M 2025-12
Vinci EUR 41.93B 11.14B 2025-12